Therefore, the action of IL-1α may suffice to allow cell migration and compensatory remodeling when targeting IL-1β to reduce inflammation in atherosclerosis, avoiding the potentially adverse effects of abrogation of signaling by both isoforms noted in IL-1R1-deficient mice.[9]. This evidence concerns the gene IL1A and atherosclerosis.